We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Revitalization Bill Progresses In Senate

Law360 (April 19, 2007, 12:00 AM EDT) -- A Senate Committee approved a bill Wednesday that would require the U.S. Food and Drug Administration to monitor safety of new drugs and renew a law allowing the agency to collect fees from drug companies and medical device manufacturers.

The bill, sponsored by Sens. Edward Kennedy (D-Mass.) and Michael Enzi (R-Wyo.) the chairman and ranking member of the Senate Health, Education, Labor and Pensions Committee, passed by a 15-5 vote.

The Prescription Drug User Fee Act, which allows the FDA to charge user fees for such...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.